An association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13

Haematologica

Volumn 92, Issue 2, 2007, Pages

  Davies, James Anthony ^a   Bowen, Derrick John ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ADAMTS13; Proteolysis; V L1565; Von Willebrand factor; Y C1584

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; CYSTEINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE FREQUENCY; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ANIMAL; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; METABOLISM; PROTEIN TERTIARY STRUCTURE; SPECIES DIFFERENCE;

ADAM PROTEINS; ALLELES; ANIMALS; COHORT STUDIES; CYSTEINE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY; VON WILLEBRAND FACTOR;

EID: 33947519502     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10633     Document Type: Article

References (17)

1. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multirners. Cell 1986;46:185-90.
2. Sporn LA, Marder VJ, Wagner DD. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 1987;69:1531-4.
3. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-34.
4. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996;87:4235-44.
5. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri Z. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990;87:6306-10.
6. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle P, Brenner B, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
7. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-94.
8. Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS 13. J Thromb Haemost 2003;1:33-40.
9. O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood 2005; 106:1988-91.
10. Bowen DJ, Collins PW. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood 2004;103:941-7.
11. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-5.
12. O'Brien LA, James PD, Othman M, Berber E, Cameron C, Notley CR, et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102:549-57.
13. Bowen DJ, Collins PW. Insights into von Willebrand factor proteolysis: clinical implications. Br J Haematol 2006; 133:457-67.
14. Savage DA, Wood NA, Bidwell JL, Fitches A, Old JM, Hui KM. Detection of b-thalassaemia mutations using DNA heteroduplex generator molecules. Br J Haematol 1995;90:564-71.
15. Short PE, Williams CE, Picken AM, Hill FG. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci 1982;39:351-5.
16. Gerritsen HE, Turecek PL, Schwarz HP, Lammle B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999; 82:1386-9.
17. Raines G, Aumann H, Sykes S, Street A. Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gels. Thromb Res 1990;60:201-12.